Home > Financial Ratios > GENNEX LABORATORIES

GENNEX LABORATORIES
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for GENNEX LABORATORIES
Please provide your vote to see the results

GENNEX LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 153.7027.91-4.2368.10-12.63

What is the latest Core EBITDA Growth ratio of GENNEX LABORATORIES ?

The latest Core EBITDA Growth ratio of GENNEX LABORATORIES is 153.70 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar2024153.70
Mar202327.91
Mar2022-4.23
Mar202168.10
Mar2020-12.63

How is Core EBITDA Growth of GENNEX LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2024 153.7
450.70
Mar2023 27.91
Positive
Mar2022 -4.23
Negative
Mar2021 68.1
Positive
Mar2020 -12.63 -

Other Financial Ratios of GENNEX LABORATORIES


Compare Core EBITDA Growth ratio of peers of GENNEX LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENNEX LABORATORIES ₹310.6 Cr -1.9% 8.3% -4.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,551.0 Cr -0.1% 1.3% 5% Stock Analytics
DIVIS LABORATORIES ₹175,704.0 Cr -1.7% 0.5% 47.2% Stock Analytics
CIPLA ₹123,675.0 Cr 0.4% -1.5% -1.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,925.0 Cr -0.2% 9% 13.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,626.0 Cr 0.5% -5.7% -9.1% Stock Analytics


GENNEX LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENNEX LABORATORIES

-1.9%

8.3%

-4.8%

SENSEX

-0.4%

-1.6%

1.3%


You may also like the below Video Courses